Definium MNMD 深 沪
交易中 10-06 10:12:58 美东时间
15.02
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 15.02
- 总市值 633.84万
- 52周最高 15.29
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.71
- 委 比 0.00%
- 总股本 0.00亿
- 历史最高 86.55
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.10
- 每 手 1
- 风险率 0.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Definium Says Its Anxiety Drug Showed 'Unprecedented Efficacy'
Definium Therapeutics announced positive Phase 3 Panorama trial results for DT120 in generalized anxiety disorder patients.
09-14 23:13
Definium Therapeutics Plans To Commence $500M Common Stock Offering
Definium Therapeutics, Inc. (NASDAQ:DFTX) (the "Company" or "Definium"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes
06-23 04:01
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 points on Monday. The Dow traded up 0.28% to 51,709.06 while the NASDAQ fell 1.31% to 26,170.77. The S&P 500 also
06-23 00:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-market session. The company's market cap stands at $4.0 million. Aditxt (NASDAQ:ADTX) shares rose 84.99% to $0.02.
06-22 20:05
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-03-07 22:04
'DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands' - Marijuana Moment
https://www.marijuanamoment.net/dea-calls-for-massive-increases-in-psilocybin-ibogaine-and-thc-manufacturing-this-year-to-meet-research-demands/The Drug Enforcement Administration (DEA) is proposing a dramatic increase
2024-09-24 01:41
Canaccord Genuity Maintains Buy on Mind Medicine, Lowers Price Target to $14
Canaccord Genuity analyst Sumant Kulkarni maintains Mind Medicine (NASDAQ:MNMD) with a Buy and lowers the price target from $16 to $14.
2024-09-16 22:19
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI advancements in drug development.
2024-09-06 00:53
